Sharmilee M Nyenhuis is an expert in Immunology at University of Chicago (United States). As of October 2026, ScienceLeadR ranks Sharmilee M Nyenhuis in the top 1% of experts worldwide for Asthma, Hypersensitivity and Lung Diseases, Obstructive. Sharmilee M Nyenhuis has authored 157 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 1 of them ongoing. SLR score: 831 (community average: 125). How the SLR is computed.

LeadR Profile

Sharmilee M Nyenhuis University of Chicago United States
831 ScienceLeadR Reputation 831
Network Map

Immunology

Subspecialties: Otolaryngology - Pulmonology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2008 - 2026

Source: PubMed

University of Chicago Medical Center

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Perceptions of Climate Change, Health Impacts, and Climate Resilience, among Urban Residents Living with Asthma: An Exploratory Qualitative Study.
PMID 42850551 — climate, perception, asthma
J Urban Health20260
Asthma in the Intensive Care Unit: Changing Patterns, Persistent Challenges.
PMID 42765335 — intensive care units, asthma
Ann Am Thorac Soc20260
An IL-6 high phenotype in children with asthma is associated with obesity and neutrophilia.
PMID 42735798 — diabetes mellitus, hypersensitivity, interleukin-6, phenotype, immunity, obesity, asthma, child, plasma
Ann Allergy Asthma Immunol20260
Editorial: Advancing equity in allergic disease management through innovative clinical strategies.
PMID 42548682 — disease management, asthma
Front Allergy20260
Use of Stigmatizing Language in Pediatric Clinician Notes.
PMID 42386200 — language, chronic disease, pediatrics
Hosp Pediatr20260

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 4
Phase 2/Phase 3 1
Phase 3 1

By status:

Completed 5
Active not recruiting 1

By type:

Interventional 5
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 2
multicentric5to9 1
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Physical Activity Intervention for Black Women With Asthma
NCT05726487 — exercise, life style, motor activity, maintenance, asthma, sedentary behavior, education, women
N/AActive not recruiting2023

LeadR Networks

Main global connection map